U.S. FDA Wary About “Paying The Price” For Mistakes Based On Foreign Data
This article was originally published in PharmAsia News
Executive Summary
It is going to take time for the public and policymakers to get comfortable with the idea of U.S. FDA making regulatory decisions based on information from other countries, Commissioner Hamburg says.